HyperSpectral’s chasing the stuff you can’t even see. The Alexandria-based AI startup just locked in a $7M Series A-2 led by RRE Ventures & Kibo Ventures, with Avalanche Thinking jumping in and returning believers Correlation Ventures & GC&H Investments doubling down. That pushes their total raise to $15.5M, not bad for a crew built to see beyond the visible spectrum.
Co-Founders Matt Theurer and Lauren Stack aren’t new to building systems that bend the laws of what’s possible. Theurer helped turn Virtustream into a $1.2B exit before cloud computing was cool. Now, with Stack orchestrating operations like a Swiss watch with attitude, HyperSpectral’s doing for spectral data what GPUs did for graphics, making sense of chaos at machine speed.
Their SpecAI™ platform doesn’t care which spectrometer, camera, or sensor you use, it plugs in, scans, and reads the invisible signatures hiding in your materials. It’s chemistry meets code, with AI models trained across proprietary and open datasets to detect pathogens, toxins, or counterfeit materials in minutes. No petri dish, no lab coat, just clean data-driven truth in real time.
Defense? Covered. Food safety? Already piloting with Case Western Reserve University & Safe Food Alliance. MedTech? In the mix. They’ve even caught DARPA’s eye, because when your tech sees what humans can’t, it tends to get noticed.
Chairman Dr. Vincent D. “Chuck” Mattera brings his optical industry war chest to the table, while investors like Will Porteous at RRE Ventures and Juan López at Kibo Ventures are betting this team’s spectral vision can rewrite how industries validate what’s real.
This $7M isn’t about buying time, it’s about buying acceleration. The plan? Expand SpecAI™, scale the dataset engine, and grow the squad that’s turning photons into proof. From Alexandria to Cambridge to wherever data hides next, HyperSpectral isn’t just building tech, it’s tuning the frequency of truth.
